Canopy Growth Corporation (CGC)
NASDAQ: CGC · Real-Time Price · USD
1.050
0.00 (0.00%)
At close: Aug 21, 2026, 4:00 PM EDT
1.058
+0.008 (0.76%)
After-hours: Aug 21, 2026, 7:58 PM EDT
Canopy Growth Revenue
Canopy Growth had revenue of 81.17M CAD in the quarter ending June 30, 2026, with 12.52% growth. This brings the company's revenue in the last twelve months to 293.63M, up 6.81% year-over-year. In the fiscal year ending March 31, 2026, Canopy Growth had annual revenue of 284.60M with 5.80% growth.
Revenue (ttm)
293.63M CAD
Revenue Growth
+6.81%
P/S Ratio
2.17
Revenue / Employee
260,314 CAD
Employees
1,128
Market Cap
448.57M USD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 284.60M | 15.61M | 5.80% |
| Mar 31, 2025 | 269.00M | -28.15M | -9.47% |
| Mar 31, 2024 | 297.15M | -36.11M | -10.83% |
| Mar 31, 2023 | 333.25M | -142.45M | -29.94% |
| Mar 31, 2022 | 475.70M | -70.95M | -12.98% |
| Mar 31, 2021 | 546.65M | 147.88M | 37.08% |
| Mar 31, 2020 | 398.77M | 172.43M | 76.18% |
| Mar 31, 2019 | 226.34M | 148.39M | 190.37% |
| Mar 31, 2018 | 77.95M | 38.05M | 95.38% |
| Mar 31, 2017 | 39.90M | 27.20M | 214.16% |
| Mar 31, 2016 | 12.70M | 10.33M | 435.60% |
| Mar 31, 2015 | 2.37M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Tilray Brands | 915.45M |
| Evotec SE | 819.47M |
| Emergent BioSolutions | 770.20M |
| Ironwood Pharmaceuticals | 389.32M |
| Evolus | 316.49M |
| Aurora Cannabis | 221.16M |
| Kamada | 191.85M |
| Anika Therapeutics | 120.65M |
CGC News
- 5 days ago - Top Canadian Cannabis Stocks to Watch in August 2026 - MarijuanaStocks
- 6 days ago - Canopy Growth Proxy statement: Proxy filing - Filings
- 6 days ago - Canopy Growth announces mailing of proxy materials for special meeting - TheFly
- 6 days ago - Canopy Growth Announces Mailing of Proxy Materials for 2026 Annual General and Special Meeting – Urges Shareholders to Vote Now - Business Wire
- 7 days ago - Canopy Growth secures renewed EU GMP certification at Kincardine - TheFly
- 7 days ago - Curaleaf Wants to Buy Aurora Cannabis for $272 Million. Is Canopy Growth the Next Marijuana Takeover Target? - The Motley Fool
- 8 days ago - Marijuana reform is emerging as a midterm elections issue on both sides of the aisle - CNBC
- 9 days ago - Canopy Growth (CGC) Q1 2027 Earnings Call Transcript - The Motley Fool